OLD National Bancorp IN Sells 1,221 Shares of The Clorox Company (NYSE:CLX)

OLD National Bancorp IN cut its holdings in The Clorox Company (NYSE:CLX) by 12.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 8,653 shares of the company’s stock after selling 1,221 shares during the quarter. OLD National Bancorp IN’s holdings in Clorox were worth $1,405,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Swedbank AB boosted its stake in shares of Clorox by 16.9% during the fourth quarter. Swedbank AB now owns 48,984 shares of the company’s stock valued at $7,955,000 after purchasing an additional 7,068 shares in the last quarter. Robeco Institutional Asset Management B.V. lifted its holdings in Clorox by 49.0% during the fourth quarter. Robeco Institutional Asset Management B.V. now owns 370,880 shares of the company’s stock worth $60,235,000 after buying an additional 121,979 shares during the period. IRON Financial LLC boosted its position in Clorox by 2.8% during the 4th quarter. IRON Financial LLC now owns 5,512 shares of the company’s stock valued at $895,000 after acquiring an additional 151 shares in the last quarter. Slow Capital Inc. increased its holdings in shares of Clorox by 0.8% in the 4th quarter. Slow Capital Inc. now owns 18,462 shares of the company’s stock valued at $2,998,000 after acquiring an additional 142 shares during the period. Finally, Webster Bank N. A. raised its position in shares of Clorox by 36.8% in the 4th quarter. Webster Bank N. A. now owns 520 shares of the company’s stock worth $84,000 after acquiring an additional 140 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors.

Clorox Stock Down 1.2 %

Shares of CLX opened at $158.60 on Friday. The firm has a market cap of $19.63 billion, a PE ratio of 55.26, a price-to-earnings-growth ratio of 2.91 and a beta of 0.42. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08. The company’s fifty day moving average is $162.98 and its two-hundred day moving average is $158.03. The Clorox Company has a fifty-two week low of $127.60 and a fifty-two week high of $171.37.

Clorox (NYSE:CLX) last posted its earnings results on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The business had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.64 billion. During the same quarter last year, the firm earned $0.49 earnings per share. The company’s revenue for the quarter was up 27.0% compared to the same quarter last year. Analysts forecast that The Clorox Company will post 6.86 earnings per share for the current year.

Clorox Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be paid a $1.22 dividend. The ex-dividend date is Wednesday, January 29th. This represents a $4.88 dividend on an annualized basis and a dividend yield of 3.08%. Clorox’s dividend payout ratio (DPR) is presently 170.04%.

Wall Street Analyst Weigh In

Several research analysts recently commented on CLX shares. StockNews.com lowered shares of Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. Wells Fargo & Company upgraded Clorox from an “underweight” rating to an “equal weight” rating and upped their target price for the company from $155.00 to $157.00 in a research report on Tuesday, January 7th. TD Cowen raised Clorox from a “sell” rating to a “hold” rating and increased their price target for the stock from $155.00 to $170.00 in a research report on Wednesday, November 6th. Evercore ISI cut their target price on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating for the company in a report on Monday, October 14th. Finally, JPMorgan Chase & Co. upped their price target on Clorox from $167.00 to $171.00 and gave the stock a “neutral” rating in a report on Thursday, January 16th. Four analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has assigned a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $156.07.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.